Test Price
2,800 AED✅ Home Collection Available
GRHL3 Gene Van der Woude Syndrome Type 2 Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines
تحليل جين GRHL3 لمتلازمة فان دير فوود النوع الثاني في الإمارات | 2,800 درهم | إرشادات هيئة الصحة بدبي 2026
يقدم هذا الفحص الجيني الشامل تسلسلاً جينيًا من الجيل التالي للكشف عن الطفرات المسببة لمتلازمة فان دير فوود النوع الثاني بدقة تصل إلى 99.9% وفق معايير هيئة الصحة بدبي لعام 2026.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Hospital‑Grade Home Collection (8 AM–11 PM) with ISO Certified Cold‑Chain transport and VIP Mobile Phlebotomy.
- Clinical Guidance: Complimentary telephonic post‑test clinical guidance for result interpretation by our DHA‑licensed team.
- Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
This next‑generation sequencing (NGS) panel analyses the entire coding region of the GRHL3 gene to identify pathogenic variants responsible for Van der Woude syndrome type 2, a rare autosomal dominant disorder presenting with lower lip pits and cleft lip/palate. يكشف هذا التحليل عن التغيرات الجينية في جين GRHL3 المسبب للمتلازمة، مما يساعد في تأكيد التشخيص السريري واتخاذ القرارات العلاجية.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Molecular Method | High‑depth NGS (Next Generation Sequencing) | Sanger sequencing of a single amplicon |
| Variant Detection | Single nucleotide, small indels, copy number changes (if covered) | Limited to point mutations and small indels |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Cost (AED) | 2,800 | ~2,500 |
| DHA Compliance | Fully compliant with Federal Decree‑Law No. 41 of 2024, Art. 87; CDS Law 2026 for minors | Variable |
Physician Insight & Safety Protocol
"As a clinician, I recognise the profound anxiety families experience when facing a potential diagnosis of Van der Woude syndrome. This NGS test provides definitive molecular confirmation that guides surgical planning and genetic counselling; however, results must always be correlated with physical findings and a detailed family pedigree. Do not rely on genetic data in isolation—multidisciplinary evaluation remains the cornerstone of safe, patient‑centred care."
— Dr. Prabhakar Reddy (DHA License: 61713011), Consultant Pediatrician
⚠️ Medication Warning: Do not discontinue any prescribed medication without explicit instruction from your attending physician. Genetic test results are not a substitute for ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals under 18 years must have a legal guardian’s consent and complete mandated pre‑test genetic counselling (CDS Law 2026).
- Exclusion: This test is not designed for acute medical crises; it should not replace immediate clinical assessment in emergency settings.
- Exclusion: The assay is not validated for standalone prenatal diagnosis without concurrent ultrasound and invasive sampling (amniocentesis/CVS).
- ER Red Flag: Newborns with confirmed or suspected Van der Woude syndrome who present with severe respiratory distress, cyanosis, or feeding difficulties must be taken to the nearest emergency department without delay.
- ER Red Flag: Sudden onset of aspiration pneumonia or airway obstruction requires immediate hospital attention.
Pre‑Test Requirements
A comprehensive clinical history of the proband and a formal genetic counselling session to construct a detailed family pedigree are mandatory before sample collection. The counselling will assess inheritance patterns and inform variant interpretation according to UAE PDPL and DHA standards.
Patient FAQ & Clinical Guidance
Q: What is the purpose of the GRHL3 gene test for Van der Woude syndrome type 2?
This NGS test detects pathogenic mutations in GRHL3 gene to confirm a clinical diagnosis of Van der Woude syndrome type 2. It identifies variants that cause lower lip pits, cleft lip/palate, and related craniofacial anomalies, enabling early surgical planning and genetic counselling for affected families.
ما هو الهدف من فحص جين GRHL3 لمتلازمة فان دير فوود النوع الثاني؟
يكتشف هذا التحليل الطفرات المسببة للمرض في جين GRHL3، مما يؤكد التشخيص السريري لمتلازمة فان دير فوود النوع الثاني ويساعد في التخطيط الجراحي والاستشارة الوراثية.
Q: How long do results take and what is the cost?
Turnaround time is 3–4 weeks from sample receipt and the price is 2,800 AED inclusive of all laboratory fees and DHA reporting. This interval allows rigorous NGS data analysis, bioinformatic interpretation, and a comprehensive clinical report audited by a board‑certified molecular geneticist.
كم تستغرق النتائج وكم تبلغ التكلفة؟
تظهر النتائج خلال 3 إلى 4 أسابيع من استلام العينة، وتبلغ التكلفة 2,800 درهم إماراتي شاملة جميع الرسوم وتقرير هيئة الصحة بدبي.
Q: Do I need a doctor’s referral or genetic counselling?
Yes, a physician referral and pre‑test genetic counselling are mandatory to interpret results accurately and comply with UAE regulations. This ensures that results are linked to the correct clinical indication and that families receive proper risk assessment and psychosocial support under the UAE Genetic Testing Law.
هل أحتاج إلى إحالة طبية أو استشارة وراثية؟
نعم، الإحالة الطبية والاستشارة الوراثية قبل الفحص إلزاميتان لتفسير النتائج بدقة والامتثال للوائح دولة الإمارات العربية المتحدة.
UAE Legal Compliance: This testing service adheres to Federal Decree‑Law No. 41 of 2024 (Article 87) on Genetic Health Services, the 2026 Communicable Disease Surveillance Law for Minors, and the UAE Personal Data Protection Law (PDPL). All patient data is processed in ISO 27001‑certified secure servers.
ISO Certification: ISO 9001:2015 – Cert No. INT/EGQ/2509DA/3139.
Facility License: 9834453 (DHA/MOHAP).
24/7 Support: Call or WhatsApp +971 54 548 8731 for home collection booking, insurance verification, or clinical inquiries.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians